Food Safety Testing MarketSize, Share & Industry Analysis, 2026-2034By Test TypeBy ApplicationBy TechnologyBy Testing Site (Service)By End User

Food safety testing covers the laboratory and on-site analytical services used to detect pathogens, allergens, chemical residues, toxins and genetically modified content in food and beverage products before and after they reach the market. It spans microbiological culture and rapid molecular methods, immunoassay and chromatography-based chemical analysis, and the accredited third-party laboratories, in-house quality teams and contract testing networks that perform this work. Buyers include food and beverage manufacturers meeting regulatory release requirements, retailers and foodservice operators verifying supplier compliance, and certification bodies and regulators auditing the food supply chain.

The global food safety testing market is valued at USD 26.4 billion in 2025 and is set to reach USD 53.45 billion by 2034, a compound annual growth rate of 8.11% across the 2026-2034 forecast period. The study tracks the market across USD 18.4 billion in 2020, USD 24.8 billion in 2024, USD 28.65 billion in 2026 and USD 39.45 billion in 2030.

Composition changes more than the total does. Allergen Testing, at 10.8%, outgrows Residues & Contamination Testing at 7.41%, and its share moves from 12% to 15%. Microbiological Testing stays the largest line throughout, at USD 9.5 billion in 2025 and USD 18.17 billion in 2034. The lines gaining share are Allergen Testing and Genetically Modified Organism (GMO) Testing. Microbiological Testing, Chemical & Nutritional Testing, Residues & Contamination Testing and Others lose share without losing revenue.

By application, Meat, Poultry, & Seafood Product accounts for 32% of 2025 revenue at USD 8.45 billion, reaching USD 16.04 billion and 30% by 2034. Beverages grows faster at 9.3% against 7.38%, moving from 10% of revenue to 11% by 2034. This axis divides the same revenue as the test type split rather than adding to it, so the two are read together rather than summed.

North America is the largest region at 30% of 2025 revenue, worth USD 7.92 billion and reaching USD 14.43 billion by 2034. Europe follows at 28%, moving from USD 7.39 billion to USD 13.36 billion, and Middle East and Africa is the smallest at 7%. Asia Pacific and Latin America gain share across the period, so growth is not distributed evenly between regions.

Behind these figures sit five regions, six test type lines and five segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is a triangulation of published figures and category proxies rather than a directly sourced total, and the same applies to the segment, regional and country breakdowns drawn from it.

• A forecast-period rate of 8.11% takes the market from USD 26.4 billion in 2025 to USD 53.45 billion in 2034, against 7.49% recorded over the 2020-2025 historical period.
• Microbiological Testing is the largest test type line at USD 9.5 billion in 2025, a 36% share, reaching USD 18.17 billion and 34% of revenue by 2034.
• Allergen Testing is the fastest-growing line at 10.8%, lifting its share from 12% in 2025 to 15% in 2034 and its revenue from USD 3.17 billion to USD 8.02 billion.
• The bull case puts 2034 revenue at USD 58.8 billion and the bear case at USD 48.11 billion, either side of the USD 53.45 billion base case, each with its own stated assumption in the full report.
• North America holds 30% of global revenue in 2025 at USD 7.92 billion, the largest of the five regions tracked, and reaches USD 14.43 billion by 2034.
• 78% of North America's base-year revenue comes from the United States alone: USD 6.18 billion in 2025, rising to USD 11.11 billion by 2034, which is why it is that region's worked example.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

Three movements define the forecast period in the global food safety testing market: how the test type mix changes, where regional weight shifts, and the rate at which the total compounds.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; the question is which takes the larger part of the growth.

Allergen Testing outpaces Residues & Contamination Testing. The widest spread on the test type axis is between Allergen Testing at 10.8% and Residues & Contamination Testing at 7.41%. Allergen Testing takes its share of revenue from 12% to 15% while Residues & Contamination Testing gives up ground, from 18% to 17%. Neither contracts: USD 3.17 billion becomes USD 8.02 billion, USD 4.75 billion becomes USD 9.09 billion. What the spread decides is which of them a supplier's revenue is exposed to.

Regional weight shifts toward Asia Pacific and Latin America. Asia Pacific moves from 27% of revenue in 2025 to 32% in 2034, worth USD 7.13 billion rising to USD 17.1 billion; Latin America moves from 8% of revenue in 2025 to 9% in 2034, worth USD 2.11 billion rising to USD 4.81 billion. The offsetting side is North America at 30% moving to 27%, Europe at 28% moving to 25%, Middle East and Africa at 7% moving to 7%, none of which contracts. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

Fifteen years without a discontinuity. Year by year the total runs USD 18.4 billion in 2020, USD 24.8 billion in 2024, USD 26.4 billion in 2025, USD 28.65 billion in 2026, USD 39.45 billion in 2030 and USD 53.45 billion in 2034. There is no discontinuity to time, and 8.11% forecast growth against 7.49% historical means the trend continues rather than turns. That moves the planning question away from timing a turn and onto the test type and regional mixes, where the actual movement is.

Allergen Testing adds the most incremental growth

Growth in the global food safety testing market comes from three measurable sources over 2026-2034: the market's own compounding at 8.11%, the share gained by faster-growing test type lines, and expansion in the regions taking a larger part of global revenue.

The bear case and what drives it

What the bull case turns on

The total depends on a single line

In North America, 30% of global revenue puts 2025 at USD 7.92 billion on the way to USD 14.43 billion by 2034. It is a leading region on this axis, first by revenue throughout the period.

27% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Within the region the test type split tracks the global one; 36% of 2025 revenue in Microbiological Testing, fastest growth of 10.8% in Allergen Testing. Per-axis and per-country detail for North America sits in the full report.

USD 6.18 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 11.11 billion by 2034. Because it is 78% of the region in the base year, North America's totals move with this one country rather than with a spread of them. Regional revenue of USD 7.92 billion in 2025 and USD 14.43 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Demand in the United States follows the test type mix reported at global level: Microbiological Testing is the largest line at 36% of 2025 revenue, moving to 34% by 2034, while Allergen Testing grows fastest at 10.8% and takes its share from 12% to 15%. With 78% of North America concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. The United States carries its own test type breakdown in the full report.

In the United States, food safety testing sits under the Food and Drug Administration's oversight of most packaged and processed foods, with the Department of Agriculture's Food Safety and Inspection Service governing meat, poultry, and egg products separately. The Food Safety Modernization Act shifted emphasis from responding to contamination toward preventive controls, requiring facilities to identify hazards and validate testing regimes accordingly. Laboratories performing this testing are increasingly expected to hold accreditation to the internationally recognized laboratory competence standard, and the FDA's Laboratory Accreditation for Analyses of Foods program formalizes recognition of accreditation bodies and the labs they certify. Suppliers of testing equipment and services must therefore demonstrate method validation and traceable accreditation rather than simply offering analytical capability.

The suppliers tracked in this study (SGS S.A., Eurofins Scientific, Intertek Group plc, Bureau Veritas S.A., ALS Ltd., Mérieux NutriSciences, AsureQuality Ltd., TÜV SÜD, TÜV Rheinland, Microbac Laboratories, Neogen Corporation, Romer Labs, bioMérieux, Charm Sciences and Thermo Fisher Scientific) compete in the United States across the test type lines above. Microbiological Testing, at 36% of 2025 revenue, is where the volume sits, and Allergen Testing, growing at 10.8%, is where position changes hands over the forecast period. Per-company positioning and share at country level are in the full report only.

Canada is sized at USD 1.5 billion in 2025, rising to USD 2.74 billion by 2034; 5.68% of global revenue and 19% of North America. It is reported separately from the United States across every segmentation axis in the full report.

In Europe, 28% of global revenue puts 2025 at USD 7.39 billion with USD 13.36 billion projected for 2034. It is a leading region on this axis, second by revenue throughout the period.

By 2034 the share stands at 25%, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

The test type mix reported at global level applies here, with Microbiological Testing the largest line at 36% of 2025 revenue and Allergen Testing the fastest-growing at 10.8%. The full report breaks Europe out along every axis and by country.

The largest single market in Europe is Germany, at USD 1.77 billion in 2025 and USD 3.07 billion in 2034. Its 24% of base-year regional revenue leads the region, though enough sits elsewhere that Europe is not a proxy for it. The region itself runs USD 7.39 billion to USD 13.36 billion over the same period, and this is the market carrying the country-level detail in the full report.

Demand in Germany follows the test type mix reported at global level: Microbiological Testing is the largest line at 36% of 2025 revenue, moving to 34% by 2034, while Allergen Testing grows fastest at 10.8% and takes its share from 12% to 15%. Because the country carries 24% of Europe, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. Per-test type revenue for Germany appears on its own in the full report.

In Germany, food safety testing operates within the European Union's General Food Law framework, which assigns risk assessment to the European Food Safety Authority while leaving official controls and enforcement to national and state authorities, chiefly the Bundesamt für Verbraucherschutz und Lebensmittelsicherheit alongside regional food control offices. The EU's Official Controls Regulation obliges competent authorities and the laboratories that support them to apply validated, standardized methods, and testing bodies are expected to hold accreditation to the internationally recognized laboratory competence standard under national accreditation bodies recognized within the European framework. Suppliers into this market must show conformity with CEN or DIN reference methods and maintain accredited status rather than rely on proprietary techniques alone.

The suppliers tracked in this study (SGS S.A., Eurofins Scientific, Intertek Group plc, Bureau Veritas S.A., ALS Ltd., Mérieux NutriSciences, AsureQuality Ltd., TÜV SÜD, TÜV Rheinland, Microbac Laboratories, Neogen Corporation, Romer Labs, bioMérieux, Charm Sciences and Thermo Fisher Scientific) compete in Germany across the test type lines above. Volume sits in Microbiological Testing at 36% of 2025 revenue; movement sits in Allergen Testing at 10.8% growth.

The United Kingdom is sized at USD 1.48 billion in 2025, rising to USD 2.54 billion by 2034; 5.61% of global revenue and 20% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

4.47% of global revenue is generated in France; USD 1.18 billion in 2025, reaching USD 2 billion in 2034, and 16% of Europe.

In Asia Pacific, 27% of global revenue puts 2025 at USD 7.13 billion on the way to USD 17.1 billion by 2034. It is a leading region on this axis, third by revenue throughout the period.

Its share rises to 32% over the forecast period, at a pace above the 8.11% global rate, which is what makes this region worth reading separately rather than scaling from the total.

Microbiological Testing leads here as it does globally, at 36% of 2025 revenue, and Allergen Testing again grows fastest at 10.8%. The full report breaks Asia Pacific out along every axis and by country.

30% of Asia Pacific's base-year revenue comes from China; USD 2.14 billion, rising to USD 5.3 billion by 2034. 30% of the region in the base year makes it the largest market here without making it the region. Against regional totals of USD 7.13 billion in 2025 and USD 17.1 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Microbiological Testing at 36% of 2025 revenue, easing to 34% by 2034, and the fastest is Allergen Testing at 10.8%, from 12% to 15%. Since 30% of Asia Pacific's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Per-test type revenue for China appears on its own in the full report.

In China, food safety testing is governed by the Food Safety Law administered under the State Administration for Market Regulation, with the National Health Commission setting the national food safety standards, known as the GB series, that define permissible contaminants and required test methods. Laboratories offering testing services generally need accreditation through the China National Accreditation Service for Conformity Assessment or recognition under the China Metrology Accreditation scheme before their results are accepted by regulators or trading partners. Suppliers of testing instruments and services operating in this market are expected to align their methods with designated national standards and to support accredited laboratories rather than offer standalone, unrecognized testing capability.

In China the field is SGS S.A., Eurofins Scientific, Intertek Group plc, Bureau Veritas S.A., ALS Ltd., Mérieux NutriSciences, AsureQuality Ltd., TÜV SÜD, TÜV Rheinland, Microbac Laboratories, Neogen Corporation, Romer Labs, bioMérieux, Charm Sciences and Thermo Fisher Scientific. Microbiological Testing, at 36% of 2025 revenue, is where the volume sits, and Allergen Testing, growing at 10.8%, is where position changes hands over the forecast period.

Within Asia Pacific, Japan accounts for 18% of regional revenue and 4.85% of the global total, worth USD 1.28 billion in 2025 and USD 2.57 billion by 2034.

Within Asia Pacific, India accounts for 14% of regional revenue and 3.79% of the global total, worth USD 1 billion in 2025 and USD 3.25 billion by 2034.

USD 2.11 billion of 2025 revenue is generated in Latin America, 8% of the global food safety testing market on the way to USD 4.81 billion by 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

Share climbs to 9% by 2034, on growth above the market's own 8.11%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Microbiological Testing leads here as it does globally, at 36% of 2025 revenue, and Allergen Testing again grows fastest at 10.8%. Latin America is reported axis by axis and country by country in the full study.

USD 0.89 billion of Latin America's 2025 revenue is generated in Brazil, the region's largest market, reaching USD 1.92 billion by 2034. It accounts for 42% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 2.11 billion in 2025 and USD 4.81 billion in 2034, it is the country the full report breaks out in detail.

Composition here matches the global split: the largest line is Microbiological Testing at 36% of 2025 revenue, easing to 34% by 2034, and the fastest is Allergen Testing at 10.8%, from 12% to 15%. Because the country carries 42% of Latin America, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. The full report reports Brazil by test type separately.

In Brazil, food safety testing falls under the joint oversight of the Agência Nacional de Vigilância Sanitária, which regulates processed and packaged food safety, and the Ministério da Agricultura, Pecuária e Abastecimento, which governs products of animal origin and agricultural commodities. Both bodies rely on accredited laboratory networks, with the national accreditation body, Cgcre, operating under Inmetro, certifying testing laboratories to the internationally recognized laboratory competence standard before their results carry regulatory weight. Suppliers entering this market are expected to align testing methods with those recognized by these agencies and to work through or achieve accredited laboratory status, since unaccredited testing results are generally not accepted for compliance or export certification purposes.

In Brazil the field is SGS S.A., Eurofins Scientific, Intertek Group plc, Bureau Veritas S.A., ALS Ltd., Mérieux NutriSciences, AsureQuality Ltd., TÜV SÜD, TÜV Rheinland, Microbac Laboratories, Neogen Corporation, Romer Labs, bioMérieux, Charm Sciences and Thermo Fisher Scientific. Microbiological Testing, at 36% of 2025 revenue, is where the volume sits, and Allergen Testing, growing at 10.8%, is where position changes hands over the forecast period.

Within Latin America, Mexico accounts for 28% of regional revenue and 2.23% of the global total, worth USD 0.59 billion in 2025 and USD 1.3 billion by 2034.

Middle East and Africa holds 7% of the global food safety testing market in 2025, worth USD 1.85 billion on the way to USD 3.74 billion by 2034. By revenue it sits fifth across the study, and the ranking does not change between 2025 and 2034.

7% of global revenue sits here in 2034, below the 2025 level, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Segment composition follows the global pattern: Microbiological Testing largest at 36% of 2025 revenue, Allergen Testing fastest at 10.8%. Middle East and Africa is reported axis by axis and country by country in the full study.

30% of Middle East and Africa's base-year revenue comes from Saudi Arabia; USD 0.56 billion, rising to USD 1.08 billion by 2034. 30% of the region in the base year makes it the largest market here without making it the region. Set against USD 1.85 billion and USD 3.74 billion for the region, it is why this market rather than a smaller one is the one reported in full.

The test type pattern in Saudi Arabia is the global one: 36% of 2025 revenue in Microbiological Testing, 34% by 2034, against 10.8% growth in Allergen Testing taking it from 12% to 15%. Its 30% weight in Middle East and Africa means those movements carry straight into the regional totals. Per-test type revenue for Saudi Arabia appears on its own in the full report.

In Saudi Arabia, food safety testing is overseen by the Saudi Food and Drug Authority, which sets food safety requirements domestically, alongside technical regulations developed through the Gulf Standardization Organization that apply across the Gulf Cooperation Council states. Testing laboratories are expected to hold accreditation from the Saudi accreditation body operating under the Saudi Standards, Metrology and Quality Organization, and to demonstrate conformity with Gulf or internationally recognized reference methods. Suppliers of testing services and equipment must show that their laboratories meet these accreditation requirements and that halal and general food safety labelling obligations are supported by traceable, validated testing, rather than presenting unaccredited or informal analytical results as compliant.

Competition in Saudi Arabia runs between the suppliers this study tracks: SGS S.A., Eurofins Scientific, Intertek Group plc, Bureau Veritas S.A., ALS Ltd., Mérieux NutriSciences, AsureQuality Ltd., TÜV SÜD, TÜV Rheinland, Microbac Laboratories, Neogen Corporation, Romer Labs, bioMérieux, Charm Sciences and Thermo Fisher Scientific. Microbiological Testing, at 36% of 2025 revenue, is where the volume sits, and Allergen Testing, growing at 10.8%, is where position changes hands over the forecast period.

South Africa is sized at USD 0.41 billion in 2025, rising to USD 0.79 billion by 2034; 1.55% of global revenue and 22% of Middle East and Africa. It is reported separately from Saudi Arabia across every segmentation axis in the full report.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Test Type, Application, Technology, Testing Site (Service), End User, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.